Promote Your Attorney Profile on Law.net - Get Found / Earn More!
Optical Illusion that Expose Your Thinking
Optical Illusion that Expose Your Thinking
Pre-Game Speech from NFL Analyst Worth the Watch
Pre-Game Speech from NFL Analyst Worth the Watch
Chinese Coal Magnates Throw the Biggest Weddings
Chinese Coal Magnates Throw the Biggest Weddings
2015 Best Colleges Announced by U.S. News & World Report
2015 Best Colleges Announced by U.S. News & World Report
Job Listings

Australian Court Allows Patenting of Human Genetic Material

On Friday, an Australian court ruled that genetic material related to cancer can be patented by two technology companies.

A similar case is pending before the U.S. Supreme Court and scheduled for hearing on April 15.

Cancer support groups opposed the finding and said the ruling that allows U.S.-based Myriad Genetics Inc and Melbourne-based Genetic Technologies Ltd to hold a patent on human genetic material can lead to stifling new cancer research.

The material, BRCA1, which is being allowed patent in Australia, is associated with high-risk hereditary breast and ovarian cancer. The issue, which is going to influence the lives of billions of woman worldwide, now, and in the future, now remains to be judged by the U.S. Supreme Court.

What

 job title, keywords

Where

 city, state, zip



Get JD Journal in Your Mail
Subscribe to our FREE daily news alerts and get the latest updates on the most happening events in the legal, business, and celebrity world. You also get your daily dose of humor and entertainment!!


Trial judge John Nicholas, who found for the companies in Australia, however observed despite public sentiments that “It would lead to very odd results if a person whose skill and effort culminated in the isolation of a micro-organism … could not be independently rewarded by the grant of a patent.”

He also reasoned that the material in question could be allowed to be patented as it could not survive naturally on its own either inside or outside the human body – it needed cancer cells to survive.

Ian Olver, the chief executive of the Australian Cancer Council said the finding would help private companies to monopolize genetic mutation tests linked to breast and ovarian cancer. He said the law needs to be amended to protect humanity “from gene monopolies.”

If the companies can manage to win in U.S., anyone who wants access to the genetic material would need to pay high rates. However, it might be extremely difficult or impossible to patent and monopolize such human genetic material that holds out hope to millions of women, in U.S.

Australian Court Allows Patenting of Human Genetic Material by

Tagged: , ,

Posted by on February 15, 2013. Filed under Breaking News,Health,Medicine and Drugs. You can follow any responses to this entry through the RSS 2.0. You can skip to the end and leave a response. Pinging is currently not allowed.

 

 

Job of the Day
Experienced Attorneys
USA-CA-Los Angeles

LA firm seeks experienced attorneys. Must have experience with traffic and criminal cases, including DUIs and misdemeanors. Experience with expungements a plus. Responsibilities will include legal res...